International bank for foot-and-mouth disease vaccine: assessment of Montanide ISA 25 and ISA 206, two commercially available oil adjuvants

Vaccine
P BarnettT R Doel

Abstract

The International Vaccine Bank at Pirbright has recently installed large-scale vaccine formulation equipment for the preparation of oil-adjuvanted vaccines. Such vaccines are claimed to offer a number of advantages over Al(OH)3, particularly their ability to raise better immunity in pigs. This paper reports on the potency in pigs, cattle and guinea-pigs of foot-and-mouth disease vaccines prepared with two novel oil adjuvants, Montanide ISA 25 and 206 (Seppic, Paris). The results indicate that vaccines adjuvanted with these oils retain potency for a longer period than our conventional aqueous formulation, following storage at +4 degrees C, and elicit good antibody responses in both pigs and cattle regardless of injection route. In addition they gave no evidence of toxicity or prolonged pyrexia following their administration. Local reactions at the site of inoculation were not observed in cattle vaccinated intramuscularly, even following a booster dose. Pigs vaccinated intramuscularly only showed local reactions if the volume administered exceeded the 2.0 ml dose or the animals received a second vaccination. These observations on the efficacy of such oil formulated vaccines suggest that they have potential as an alternative to th...Continue Reading

Citations

Jun 5, 2003·International Journal for Parasitology·Manmohan Singh, Derek T O'Hagan
Oct 9, 2002·Comparative Immunology, Microbiology and Infectious Diseases·P BarnettC G Schermbrucker
Mar 21, 2001·Vaccine·J AucouturierV Ganne
Feb 23, 2002·Vaccine·P V Barnett, H Carabin
Nov 13, 2008·Cytotechnology·D DattaV Chandran
Apr 10, 2008·Transboundary and Emerging Diseases·K De ClercqD K MacKay
Nov 19, 2010·Clinical and Vaccine Immunology : CVI·Jun-Jun ShaoJi-Xing Liu
Oct 16, 2001·Journal of Clinical Microbiology·J Bayry, S V Kaveri
Aug 24, 2005·Genetic Vaccines and Therapy·Ali AziziFrancisco Diaz-Mitoma
Oct 16, 2007·European Journal of Immunology·Fabio BergaminKenneth C McCullough
Nov 16, 2006·Journal of Veterinary Medicine. A, Physiology, Pathology, Clinical Medicine·S H BasagoudanavarB C Varshney
Apr 19, 2013·Clinical and Experimental Vaccine Research·Jong-Hyeon Park
Sep 23, 2014·Expert Review of Vaccines·Yimei Cao
Apr 24, 2014·Therapeutic Advances in Vaccines·Christopher B FoxThomas S Vedvick
Jun 16, 2017·Viral Immunology·Yulia BurakovaJishu Shi
Sep 2, 2017·Journal of Veterinary Science·Min-Eun ParkJong-Hyeon Park
Sep 5, 2019·Asian-Australasian Journal of Animal Sciences·Jaesung ChoSamooel Jung
Jan 4, 2017·Veterinary Microbiology·Fayna Diaz-San SegundoTeresa de Los Santos
Nov 13, 2020·ACS Applied Materials & Interfaces·Ashlynn L Z LeeYi Yan Yang

❮ Previous
Next ❯

Related Concepts

Related Feeds

Avian Influenza: Innate Immune Adjuvant

Adjuvants systems that are added to vaccines against avian influenza have be explored to enhance the innate immune system response against the virus. Here is the latest research on avian influenza and the innate immune adjuvant.

Avian Influenza: Innate Immune Adjuvant (ASM)

Adjuvants systems that are added to vaccines against avian influenza have be explored to enhance the innate immune system response against the virus. Here is the latest research on avian influenza and the innate immune adjuvant.